Trials / Unknown
UnknownNCT03195673
Safety and Efficacy of Low Dosage of Terazosin in Subjects Undergoing Carotid Artery Stenting
A Pilot Study Assessing the Safety and Efficacy of Low Dosage of Terazosin in Subjects Undergoing Carotid Artery Stenting
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 160 (estimated)
- Sponsor
- Capital Medical University · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess the safety and efficacy of low dosage of Terazosin in Carotid Artery Stenting
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Terazosin | TZ 0.5mg once a day for 3-7 days before carotid artery stenting to 30 days later. |
| PROCEDURE | Carotid artery stenting | Carotid artery stenting is an alternative treatment of carotid artery stenosis, which would be performed by experienced neuroradiologist according to the latest guideline from American Heart Association and American Stroke Association. |
Timeline
- Start date
- 2018-03-02
- Primary completion
- 2019-11-15
- Completion
- 2019-12-15
- First posted
- 2017-06-22
- Last updated
- 2018-12-11
Locations
2 sites across 1 country: China
Source: ClinicalTrials.gov record NCT03195673. Inclusion in this directory is not an endorsement.